| Literature DB >> 32228528 |
Ahmed Adem Mohammed1, Musa Mohammed Ali2, Mengistu Hailemariam Zenebe2.
Abstract
BACKGROUND: Eye infection is a public health problem in developing countries including Ethiopia. Bacteria are major causative agents of eye infections that can lead to loss of vision. The objective of this study was to determine bacterial etiology of ocular and periocular infections, antimicrobial susceptibility profile and associated factors among patients who visited the eye unit of Shashamane Comprehensive Specialized Hospital (SCSH).Entities:
Keywords: Antimicrobial susceptibility pattern; Bacteria; External eye; Infection; Risk factors
Mesh:
Substances:
Year: 2020 PMID: 32228528 PMCID: PMC7106738 DOI: 10.1186/s12886-020-01398-w
Source DB: PubMed Journal: BMC Ophthalmol ISSN: 1471-2415 Impact factor: 2.209
Sociodemographic characteristics of study participant presented with ocular and periocular infections at Eye Unit of Shashemene Comprehensive Specialized Hospital, September 1, 2018 to March 30, 2019 (N = 332)
| Variables | Frequency | Percent |
|---|---|---|
| Male | 177 | 53.3% |
| Female | 155 | 46.7% |
| 0–2 | 17 | 5.1% |
| 3–11 | 53 | 15.9% |
| 12–17 | 39 | 11.8% |
| 18–39 | 133 | 40.1% |
| ≥ 40 | 90 | 27.1% |
| Urban | 109 | 32.8% |
| Rural | 223 | 67.2% |
| Student | 126 | 37.9% |
| Farmer | 69 | 20.8% |
| Merchant | 12 | 3.6% |
| Civil servant | 56 | 16.9% |
| House Wife | 34 | 10.2% |
| Not applicablea | 35 | 10.5% |
| Single | 61 | 18.4% |
| Divorced | 1 | 0.3% |
| Married | 168 | 50.6% |
| Not applicablea | 102 | 30.7% |
| Illiterate | 27 | 8.1% |
| Elementary School | 114 | 34.3% |
| High School | 75 | 22.6% |
| College and Above | 81 | 24.4% |
| Not applicablea | 35 | 10.5% |
aUnder age
Distribution of bacterial isolates across different clinical presentation among study participants presented with ocular and periocular infections at Eye Unit of Shashemene Comprehensive Specialized Hospital, September 1, 2018 to March 30, 2019 (N = 332)
| Types of clinical presentations | Clinical presentation | Frequency of bacteria among clinical presentation |
|---|---|---|
| n (%) | n (%) | |
| Conjunctivitis | 109 (32.8) | 91 (83.5) |
| Dacryocystitis | 76 (22.9) | 35 (46.1) |
| Blepharitis | 60 (18.1) | 36 (60) |
| Trauma | 48 (14.5) | 10 (20.8) |
| Blephero-conjunctivitis | 39 (11.8) | 26 (66.7) |
Distribution of bacteria isolated from study participants with ocular and periocular infections who visited Eye Unit of Shashemene Comprehensive Specialized Hospital based on their Gram reaction, September 1, 2018 to March 30, 2019 (N = 198)
| Bacteria based on Gram reaction | Isolated bacteria | n (%) |
|---|---|---|
| 74 (37.4) | ||
| CoNS | 57 (28.8) | |
| 4 (2) | ||
| 17 (8.6) | ||
| 9 (4.6) | ||
| 8 (4) | ||
| 7 (3.5) | ||
| 6 (3) | ||
| 6 (3) | ||
| 4 (2) | ||
| 3 (1.5) | ||
| 3 (1.5) | ||
| Total | 198 | |
Types of bacteria isolated across different clinical presentation among patients with ocular and periocular infections at Shashemene Comprehensive Specialized Hospital Eye Unit, September 1, 2018 to March 30, 2019
| Bacterial isolates | Types of clinical presentation | ||||
|---|---|---|---|---|---|
| Conjunctivitis | Blepharitis | Blepharo-conjunctivitis n (%) | Dacryocystitis | Trauma | |
| 28 (30.8) | 17 (47.2) | 17 (65.4) | 5 (14.3) | 7 (70) | |
| CoNS | 19 (20.9) | 13 (36.1) | 6 (23.1) | 17 (48.6) | 2 (20%) |
| 2 (2.2) | 1 (2.8) | 1 (3.9) | – | – | |
| 5 (5.5) | 1 (2.8) | – | – | – | |
| 3 (3.3) | – | – | 1 (2.9) | – | |
| 5 (5.5) | – | 1 (3.9) | 2 (5.7) | – | |
| 2 (2.2) | – | – | 1 (2.9) | – | |
| 4 (4.4) | – | – | 2 (5.7) | – | |
| 14 (15.4) | 1 (2.8) | – | 1 (2.9) | 1 (10%) | |
| 4 (4.4) | 3 (8.3) | 1 (3.9) | 1 (2.9) | – | |
| 2 (2.2) | – | – | 1 (2.9) | – | |
| 3 (3.3) | – | – | 4 (11.4) | – | |
| Total bacteria | 91 (45.9) | 36 (18.2) | 26 (13.1) | 35 (17.7} | 10 (5.1%) |
Denominator is number of bacteria
Antimicrobial susceptibility profile of Gram-positive bacteria isolated from study participants with ocular and periocular infections at Shashemene Comprehensive Specialized Hospital Eye Unit, September 1, 2018, to March 30, 2019 (N = 135)
| Bacteria isolated | Antibiotic Pattern | Antibiotics tested | |||||||
|---|---|---|---|---|---|---|---|---|---|
| CAF | SXT | CN | TE | E | P | DA | CIP | ||
| S | 53 (71.6%) | 51 (68.9%) | 72 (97.3%) | 2 (2.7%) | 61 (82.4%) | 4 (5.4%) | 66 (89.2%) | 63 (85.1%) | |
| I | 18 (24.3%) | 16 (21.6%) | 1 (1.4%) | 15 (20.3%) | 5 (6.8%) | 1 (1.4% | 6 (8.1%) | 7 (9.5%) | |
| R | 3 (4.1%) | 7 (9.5%) | 1 (1.4% | 57 (77%) | 8 (10.8%) | 69 (93.2%) | 2 (2.7%) | 4 (5.4%) | |
CoNS | S | 44 (77.2%) | 40 (70.2%) | 49 (85.9%) | 3 (5.3%) | 49 (85.9%) | – | 54 (94.7%) | 45 (78.9%) |
| I | 9 (15.8%) | 3 (5.3%) | 4 (7%) | 4 (7%) | 2 (3.5%) | 1 (1.8%) | 1 (1.8%) | 4 (7%) | |
| R | 4 (7%) | 14 (24.6%) | 4 (7%) | 50 (87.8%) | 6 (10.5%) | 56 (98.3%) | 2 (3.5%) | 8 (14%) | |
| S | 3 (75%) | 1 (25%) | 4 (100%) | 3 (75%) | 4 (100%) | 4 (100%) | ND | ND | |
| I | – | – | – | – | – | – | ND | ND | |
| R | 1 (25%) | 3 (75%) | – | 1 (25%) | – | – | ND | ND | |
CoNS Coagulase Negative Staphylococci, CAF Chloramaphenicol, SXT Trimethoprim-Sulphametoxazole, CN Gentamicin, TE Tetracycline, E Erythromycin, P Penicillin, DA Clindamycin, CIP Ciprofloxacin, ND Not Done. S Susceptible, I Intermediate, R Resistance
Antimicrobial susceptibility profile of Gram-negative bacteria isolated from participants with ocular and periocular infections study participants with infections at Shashemene Comprehensive Specialized Hospital Eye Unit, September 1, 2018 to March 30, 2019 (N = 63)
| Bacteria isolated | Antibiotic Pattern | Antibiotics | |||||||
|---|---|---|---|---|---|---|---|---|---|
| AMC | SXT | CIP | CRO | CN | CAF | TE | P | ||
| S | ND | ND | 6 (100%) | 6 (100%) | ND | ND | 6 (100%) | 6 (100%) | |
| I | ND | ND | – | – | ND | ND | – | – | |
| R | ND | ND | – | – | ND | ND | – | – | |
| S | ND | 4 (100%) | 4 (100%) | 4 (100%) | ND | 2 (50.0%) | ND | ND | |
| I | ND | – | – | – | ND | 2 (50.0%) | ND | ND | |
| R | ND | – | – | – | ND | – | ND | ND | |
| S | 6 (75.0%) | 4 (50.0%) | 7 (87.8%) | 7 (87.8%) | 7 (87.8%) | 7 (87.8%) | 6 (75.0%) | 3 (37.5%) | |
| I | 1 (12.5%) | 2 (25.0%) | – | – | – | 1 (12.5%) | 1 (12.5%) | – | |
| R | 1 (12.5%) | 2 (25.0%) | 1 (12.5%) | 1 (22.2%) | 1 (22.2%) | – | 1 (12.5%) | 5 (62.7%) | |
| S | 3 (100%) | – | 3 (100%) | 3 (100%) | – | 3 (100%) | – | ND | |
| I | – | – | – | – | 3 (100%) | – | – | ND | |
| R | – | 3 (100%) | – | – | – | – | 3 (100%) | ND | |
| S | 3 (50.0%) | 4 (66.6%) | 6 (100%) | 6 (100%) | ND | 6 (100%) | 4 (66.6%) | ND | |
| I | 3 (50.0%) | 1 (16.7%) | – | – | ND | – | – | ND | |
| R | – | 1 (16.7%) | – | – | ND | – | 2 (33.3%) | ND | |
| S | 9 (52.9%) | 5 (29.4%) | 17 (100%) | 15 (88.2%) | 17 (100%) | 14 (82.4%) | 1 (5.9%) | ND | |
| I | 6 (35.3%) | 1 (5.9%) | – | 1 (5.9%) | – | 1 (5.9%) | 2 (11.8%) | ND | |
| R | 2 (11.8%) | 11 (64.7%) | – | 1 (5.9%) | – | 2 (11.8%) | 14 (82.4%) | ND | |
| S | 6 (66.7%) | 6 (66.7%) | 9 (100%) | 9 (100%) | 9 (100%) | 8 (88.9%) | 2 (22.2%) | ND | |
| I | 1 (11.1%) | – | – | – | – | 1 (11.1%) | 1 (11.1%) | ND | |
| R | 2 (22.2%) | 3 (33.3%) | – | – | – | – | 6 (66.7%) | ND | |
| S | – | 3 (100%) | 3 (100%) | 3 (100%) | 3 (100%) | 3 (100%) | 3 (100%) | ND | |
| I | – | – | – | – | – | – | – | ND | |
| R | 3 (100%) | – | – | – | – | – | – | ND | |
| S | 6 (85.7%) | 6 (85.7%) | 7 (100%) | 7 (100%) | 6 (85.7%) | 4 (57.1%) | 7 (100%) | ND | |
| I | – | – | – | – | – | 2 (28.6%) | – | ND | |
| R | 1 (14.3%) | 1 (14.3%) | – | – | 1 (14.3%) | 1 (14.3%) | – | ND | |
AMC Amoxicillin-clavulanic Acid, SXT Trimethoprim-sulphametoxazole, CIP Ciprofloxacin, CRO Ceftriaxone, CN Gentamicin, CAF Chloramaphenicol, TE Tetracycline, P Penicillin, ND Not Done. S Susceptible, I Intermediate, and R Resistance